Corin
Private Company
Funding information not available
Overview
Corin Group is an established, global orthopaedic medical device company that has evolved from a traditional implant manufacturer into a technology-integrated solutions provider. Its core strategy combines clinically proven implants with the Apollo robotic-assisted surgery platform, which features AI-driven preoperative planning, intraoperative robotic guidance, and cloud-based data analytics for continuous learning. This unique integration aims to deliver personalized, balanced joint replacements, improve surgical precision, and provide superior value to healthcare systems by optimizing patient recovery and implant longevity. The company operates globally, targeting the large and growing joint replacement market.
Technology Platform
Apollo Platform: A cloud-connected ecosystem for robotic-assisted orthopaedic surgery featuring AI-driven preoperative planning (BalanceBot), handheld robotic cutting guides (Apollo Robot), and intraoperative validation tools. The platform integrates with Corin's implant portfolio and uses cloud computing for continuous data collection and learning across the surgical journey.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Corin competes in the orthopaedic robotics and implants market against major players like Stryker (Mako), Zimmer Biomet (ROSA), Johnson & Johnson (VELYS), and Smith & Nephew (CORI). Its differentiation lies in combining a legacy of clinically-proven implants with a proprietary, cloud-connected robotic platform, aiming for a seamless, data-integrated surgical solution rather than a standalone robot.